Table 2.
Correlation between VCAN and clinical features
VCAN | |||
---|---|---|---|
High | Low | p Value | |
T stage | .0008 | ||
T1 | 0 | 18 | |
T2 | 13 | 62 | |
T3 | 37 | 125 | |
T4 | 33 | 57 | |
N stage | .1184 | ||
N0 | 19 | 89 | |
N1 | 25 | 71 | |
N2 | 17 | 58 | |
N3 | 22 | 44 | |
M stage | .0651 | ||
M0 | 73 | 248 | |
M1 | 10 | 14 | |
TNM stage | .0024 | ||
Stage I | 3 | 44 | |
Stage II | 27 | 90 | |
Stage III | 38 | 104 | |
Stage IV | 15 | 24 | |
Disease type | .4159 | ||
Adenomas and adenocarcinomas | 74 | 243 | |
Cystic, mucinous, and serous neoplasms | 9 | 19 |
Note: Bold values indicate that the difference is statistically significant, p < .05.